Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03064776Not ApplicableCompleted

Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

Role: collaborator

NCT02595671Not ApplicableCompleted

B-slim, a Multi-source Digital Super Coach for Sustainable Weight Loss

Role: collaborator

NCT02257606Not ApplicableCompleted

Robot-assisted Training of the Upper Limb in Persons With Multiple Sclerosis: an Randomized Controlled Trial

Role: collaborator

NCT01904344Not ApplicableCompleted

Clinical Validation of New Breathing Sensors in Patients With Respiratory Insufficiency

Role: collaborator

All 4 trials loaded